StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)

Close on Nov 17, 2026Market cap $104.43MP/E –Yield –

Organogenesis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Organogenesis's price to sales ratio was 0.3× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.2× to 2.7×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−1.1
2025Dec 31, 20251.4×+0.5
2024Dec 31, 20240.9×−0.3
2023Dec 29, 20231.2×+0.4
2022Dec 30, 20220.8×−1.9
2021Dec 31, 20212.7×+0.0
2020Dec 31, 20202.6×+0.8
2019Dec 31, 20191.8×−1.8
2018Dec 31, 20183.7×+1.9
2017Dec 29, 20171.8×–

More Organogenesis figures

See a number that looks wrong?